My watch list
my.bionity.com  
Login  

T cells that escaped immune regulation and subsequently target insulin-producing β-cells are thought to be a major contributor of type 1 diabetes (T1D) development (1). Thus, harnessing autoreactive effector T cells appears to be a central requirement for novel therapeutic approaches that are urgently needed. The studies by Lee et al. (2) and Penaranda et al. (3) in PNAS demonstrate that blockade of IL-7 signaling can revert recent onset diabetes by fostering the inhibitory programmed cell death 1 (PD-1) protein on diabetogenic T cells, thereby limiting their autoaggressive potential.pnas;109/31/12270/FIG01F1fig01Fig. 1.IL-7 and PD-1 have antagonistic effects in the regulation of immune...

Authors:   Tobias Boettler; Matthias von Herrath
Journal:   Proceedings of the National Academy of Sciences current issue
Volume:   109
Issue:   31
Year:   2012
Pages:   12270
DOI:   10.1073/pnas.1209749109
Publication date:   31-07-2012

Watchlist

This is where you can add this publication to your personal favourites.

Additional Information

Facts, background information, dossiers
More about Proceedings of the National Academy of Sciences
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE